Magnetic Resonance Imaging-Based Volumetric Analysis of Basal Ganglia Nuclei and Substantia Nigra in Patients with Parkinson’s Disease

OBJECTIVE: Parkinson’s disease (PD) is associated with well-documented morphological changes in substantia nigra and basal ganglia nuclei. This study evaluates the ability of magnetic resonance imaging to detect these changes and investigates the relationship between severity of clinical findings and degree of morphological change. This correlation may provide valuable information in early diagnosis of PD. METHODS: Sixteen patients with early stage PD, eight patients with advanced PD, and eight normal controls were studied by 3T magnetic resonance imaging. The whole brain volume and the volumes of the caudate, putamen, globus pallidus, and substantia nigra were calculated on three-dimensional reconstructed images. RESULTS: Putamen volume was significantly diminished in patients with early PD and advanced PD compared with that in controls (P < 0.05), and the percentage of atrophy was 12.5 and 26.5%, respectively. The putamen volume was negatively correlated with Hoehn and Yahr staging (r = −0.720, P < 0.001). Pallidal volume was reduced only in advanced PD (P = 0.023). There were no significant differences in total brain, caudate, or substantia nigra among these three groups CONCLUSION: Magnetic resonance imaging-based volumetric measurement is a sensitive method in the assessment of morphological changes of PD in vivo. The putamen atrophy was correlated with the severity of clinical findings. The volumetric measurement of putamen could potentially be a useful indicator of PD in the early stage.

[1]  W. Heiss,et al.  Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[2]  G. Bydder,et al.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline , 2001, Journal of Neural Transmission.

[3]  I. McKeith,et al.  MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[4]  V Kaasinen,et al.  Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Y Nakata,et al.  Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  C Kremser,et al.  Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.

[7]  Age-related structural changes in the human midbrain: an MR image study , 2001, Neurobiology of Aging.

[8]  S H Lisanby,et al.  Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. , 1993, Journal of neural transmission. Supplementum.

[9]  J. Degroot,et al.  Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.

[10]  Yoshiharu Tamakawa,et al.  The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.

[11]  J. Saint-Cyr,et al.  The subthalamic nucleus in the context of movement disorders. , 2004, Brain : a journal of neurology.

[12]  J D Speelman,et al.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[13]  R. Grossman,et al.  MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. , 1988, AJR. American journal of roentgenology.

[14]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[15]  A J Lees,et al.  Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[16]  Karl J. Friston,et al.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.

[17]  I G McKeith,et al.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.

[18]  U Klose,et al.  Reliability and exactness of MRI‐based volumetry: A phantom study , 1996, Journal of magnetic resonance imaging : JMRI.

[19]  T. Hosoya,et al.  Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. , 1999, AJNR. American journal of neuroradiology.

[20]  Michael Hutchinson,et al.  MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM) , 2003, NeuroImage.

[21]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.

[22]  J. Hedderich,et al.  Magnetic Resonance Imaging-Based Morphometry and Landmark Correlation of Basal Ganglia Nuclei , 2002, Acta Neurochirurgica.

[23]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[24]  H. Gray Gray's Anatomy , 1858 .

[25]  Koichi Okamoto,et al.  Structural changes in the midbrain with aging and Parkinson’s disease: an MRI study , 2004, Neurobiology of Aging.

[26]  A. Antonini,et al.  PET and SPECT functional imaging in Parkinson's disease. , 2004, Sleep medicine.

[27]  N. Schuff,et al.  Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[28]  Clement Hamani,et al.  Correspondence of microelectrode mapping with magnetic resonance imaging for subthalamic nucleus procedures. , 2005, Surgical neurology.

[29]  C. Summerfield,et al.  Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[30]  M Hutchinson,et al.  Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.

[31]  Karl J. Friston,et al.  Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[32]  A. Righini,et al.  Thin Section MR Study of the Basal Ganglia in the Differential Diagnosis Between Striatonigral Degeneration and Parkinson Disease , 2002, Journal of computer assisted tomography.

[33]  M. Yorubulut,et al.  T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. , 2004, Neurology India.